SMARCA4 and cancer: Wong et al. was the first to report BRG1 mutations after his group sequenced 180 cancer cell lines and found that 18 cell lines harbored nonsense or insertion/deletion mutations; however, only 9 cell lines harbored homozygous mutations that would account for the loss of BRG1 expression [20, 21].